Friday, March 1, 2019

Sanders escalates fight with Catalyst, asking FDA to allow unbranded ...

FiercePharma-19 hours ago
Sanders' request is likely referring to drug compounding regulated under Section 503A and Section 503B of the Federal Food, Drug and Cosmetic Act. The ...

No comments: